<VariationArchive RecordType="classified" VariationID="17380" VariationName="NM_001844.5(COL2A1):c.4287_4291dup (p.Tyr1431fs)" VariationType="Duplication" Accession="VCV000017380" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2017-03-08" MostRecentSubmission="2017-03-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32419" VariationID="17380">
      <GeneList>
        <Gene Symbol="COL2A1" FullName="collagen type II alpha 1 chain" GeneID="1280" HGNC_ID="HGNC:2200" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="47972967" stop="48006212" display_start="47972967" display_stop="48006212" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="48366747" stop="48398284" display_start="48366747" display_stop="48398284" Strand="-" />
          </Location>
          <OMIM>120140</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001844.5(COL2A1):c.4287_4291dup (p.Tyr1431fs)</Name>
      <CanonicalSPDI>NC_000012.12:47974114:ACGTGA:ACGTGACGTGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="47974114" stop="47974115" display_start="47974114" display_stop="47974115" variantLength="5" positionVCF="47974114" referenceAlleleVCF="T" alternateAlleleVCF="TACGTG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="48367897" stop="48367898" display_start="48367897" display_stop="48367898" variantLength="5" positionVCF="48367897" referenceAlleleVCF="T" alternateAlleleVCF="TACGTG" />
      </Location>
      <ProteinChange>Y1362fs</ProteinChange>
      <ProteinChange>Y1431fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.48367899_48367903dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.48367899_48367903dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.47974116_47974120dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.47974116_47974120dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008072.1" sequenceAccession="NG_008072" sequenceVersion="1" change="g.35384_35388dup">
            <Expression>NG_008072.1:g.35384_35388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001844.5" sequenceAccession="NM_001844" sequenceVersion="5" change="c.4287_4291dup" MANESelect="true">
            <Expression>NM_001844.5:c.4287_4291dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001835.3" sequenceAccession="NP_001835" sequenceVersion="3" change="p.Tyr1431fs">
            <Expression>NP_001835.3:p.Tyr1431fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033150.3" sequenceAccession="NM_033150" sequenceVersion="3" change="c.4080_4084dup">
            <Expression>NM_033150.3:c.4080_4084dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_149162.2" sequenceAccession="NP_149162" sequenceVersion="2" change="p.Tyr1362fs">
            <Expression>NP_149162.2:p.Tyr1362fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="120140.0030" DB="OMIM" />
        <XRef Type="rs" ID="2136504869" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001844.5(COL2A1):c.4287_4291dup (p.Tyr1431fs) AND Spondyloperipheral dysplasia" Accession="RCV000018923" Version="28">
        <ClassifiedConditionList TraitSetID="5715">
          <ClassifiedCondition DB="MedGen" ID="C0796173">Spondyloperipheral dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-05-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-05-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-03-08" MostRecentSubmission="2017-03-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8723097</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5715" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3840" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spondyloperipheral dysplasia-short ulna syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Spondyloperipheral dysplasia</ElementValue>
                <XRef ID="Spondyloperipheral+dysplasia/6843" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010078" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spondyloperipheral dysplasia with short ulna</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4994" />
                <XRef ID="4994" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31021589</ID>
                <ID Source="BookShelf">NBK540447</ID>
              </Citation>
              <XRef ID="1856" DB="Orphanet" />
              <XRef ID="C0796173" DB="MedGen" />
              <XRef ID="MONDO:0010078" DB="MONDO" />
              <XRef Type="MIM" ID="271700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39208" SubmissionDate="2017-03-02" DateLastUpdated="2017-03-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120140.0030_SPONDYLOPERIPHERAL DYSPLASIA" title="COL2A1, 5-BP DUP_SPONDYLOPERIPHERAL DYSPLASIA" />
        <ClinVarAccession Accession="SCV000039208" DateUpdated="2017-03-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-05-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Zabel et al. (1996) described a 5-bp duplication in exon 51 of the COL2A1 gene, leading to a stop codon, in a patient with a distinct phenotype labeled spondyloperipheral dysplasia (271700). The mutation was present in heterozygous state and the patient was sporadic (new mutation). The patient, a girl, was born to healthy, nonconsanguineous parents and was 45 cm at birth. A skeletal dysplasia was suspected because of rhizomelic shortening of the arms and legs. X-ray findings at 7 months of age suggested SED congenita. At the age of 14 years the patient was 127.4 cm tall with short, broad fingers and very short toes II-V. Additional findings were a slightly hypoplastic midface with depressed nasal bridge, severe myopia, short neck and trunk, accentuated lumbar lordosis, and limited extension of the elbow joints. Short metacarpals were impressive in the hand x-rays, and very short toes II-V were impressive in the photograph of the feet. The 5-bp duplication was the first to be located at the C-terminal outside the helical domain of COL2A1. It seemed to affect helix formation and produced changes of chondrocyte morphology, collagen type II fibril structure, and cartilage matrix composition.</Attribute>
              <Citation>
                <ID Source="PubMed">8723097</ID>
              </Citation>
              <XRef DB="OMIM" ID="271700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL2A1" />
          </GeneList>
          <Name>COL2A1, 5-BP DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120140.0030" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPONDYLOPERIPHERAL DYSPLASIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39208" TraitType="Disease" MappingType="Name" MappingValue="SPONDYLOPERIPHERAL DYSPLASIA" MappingRef="Preferred">
        <MedGen CUI="C0796173" Name="Spondyloperipheral dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

